WCM Investment Management Portfolio holdings
AUM
$43.8B
This Quarter Return
+46.86%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$26.1B
AUM Growth
+$26.1B
(+44%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
69.35%
Holding
195
New
15
Increased
130
Reduced
16
Closed
15
Top Buys
| 1 |
lululemon athletica
LULU
|
$380M |
| 2 |
Mercado Libre
MELI
|
$203M |
| 3 |
Steris
STE
|
$187M |
| 4 |
ServiceNow
NOW
|
$153M |
| 5 |
TSMC
TSM
|
$126M |
Top Sells
| 1 |
Chubb
CB
|
$955M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$11.5M |
| 3 |
Shopify
SHOP
|
$9.16M |
| 4 |
Brink's
BCO
|
$6.32M |
| 5 |
Wingstop
WING
|
$6.17M |
Sector Composition
| 1 | Technology | 34.45% |
| 2 | Healthcare | 25.02% |
| 3 | Consumer Discretionary | 19.68% |
| 4 | Industrials | 9.19% |
| 5 | Financials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCF
126
DELISTED
Chase Corporation
CCF
| $5.31M | 0.02% | 51,813 +3,346 | +7% | +$343K |
|
127
AMN Healthcare
AMN
$796M
| $5.13M | 0.02% | 113,462 +53,371 | +89% | +$2.41M |
|
128
Surgery Partners
SGRY
$2.91B
| $5.11M | 0.02% | +441,970 | New | +$5.11M |
|
|
TRHC
129
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.1M | 0.02% | 93,220 -31,079 | -25% | -$1.7M |
|
130
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.98M | 0.02% | 63,646 +2,075 | +3% | +$162K |
|
|
BHVN
131
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.52M | 0.02% | 61,750 +2,235 | +4% | +$163K |
|
132
Regis Corp
RGS
$54M
| $4.39M | 0.02% | 536,201 +63,863 | +14% | +$522K |
|
133
Mine Safety
MSA
$6.68B
| $4.34M | 0.02% | 37,909 +1,255 | +3% | +$144K |
|
134
Iovance Biotherapeutics
IOVA
$807M
| $4.33M | 0.02% | 157,822 -36,316 | -19% | -$997K |
|
135
Glaukos
GKOS
$5.5B
| $4.27M | 0.02% | +111,061 | New | +$4.27M |
|
136
Ligand Pharmaceuticals
LGND
$3.15B
| $4.07M | 0.02% | 36,383 +2,957 | +9% | +$331K |
|
137
Fate Therapeutics
FATE
$120M
| $4.04M | 0.02% | 117,727 +4,253 | +4% | +$146K |
|
138
Insmed
INSM
$28.8B
| $4.03M | 0.02% | 146,271 +45,211 | +45% | +$1.25M |
|
|
RETA
139
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.85M | 0.01% | 24,655 +12,773 | +107% | +$1.99M |
|
|
NP
140
DELISTED
Neenah, Inc. Common Stock
NP
| $3.84M | 0.01% | 77,678 +5,871 | +8% | +$290K |
|
141
Axsome Therapeutics
AXSM
$6.05B
| $3.79M | 0.01% | 46,005 +10,484 | +30% | +$863K |
|
|
MYOK
142
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.46M | 0.01% | +35,760 | New | +$3.46M |
|
143
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.38M | 0.01% | 69,770 -27,891 | -29% | -$1.35M |
|
144
Synopsys
SNPS
$112B
| $3.36M | 0.01% | 17,230 +8,769 | +104% | +$1.71M |
|
145
BridgeBio Pharma
BBIO
$9.89B
| $3.24M | 0.01% | 99,273 +33,050 | +50% | +$1.08M |
|
146
Amazon
AMZN
$2.44T
| $2.93M | 0.01% | 1,062 | – | – |
|
147
Netflix
NFLX
$513B
| $2.73M | 0.01% | 6,000 -11,291 | -65% | -$5.14M |
|
148
Simulations Plus
SLP
$285M
| $2.53M | 0.01% | 42,218 -1,155 | -3% | -$69.1K |
|
149
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.25M | 0.01% | 126,176 +4,622 | +4% | +$82.6K |
|
|
TPTX
150
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.14M | 0.01% | +33,072 | New | +$2.14M |
|